Partnering

Partnering is a fundamental part of UCB’s corporate strategy and daily business.

Through partnering, we intend to

• Optimise our product portfolio by bringing
  Discovery, research and early clinical stage collaborations in our Areas of Focus.
  Phase III, pre-registration and marketed products in the areas of CNS, inflammation (including respiratory) and oncology 
• Establish partnerships that will maximise the value of UCB's core assets
• License or divest non-core assets

We are open to discuss any ideas, products, technologies or collaborations with you that may be of benefit for both parties.

Fast partnering process

At UCB, we have developed a fast, straightforward and flexible partnering process which consists of four steps:
We realise that each opportunity is unique and so we remain flexible in our approach to make sure we adapt to any potential partner-specific need.